These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15225775)

  • 1. Breast cancer cell regulation by high-dose Vitamin D compounds in the absence of nuclear vitamin D receptor.
    Valrance ME; Welsh J
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):221-5. PubMed ID: 15225775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.
    Zinser GM; McEleney K; Welsh J
    Mol Cell Endocrinol; 2003 Feb; 200(1-2):67-80. PubMed ID: 12644300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
    Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG
    J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targets of vitamin D receptor signaling in the mammary gland.
    Welsh J
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D and prevention of breast cancer.
    Welsh J
    Acta Pharmacol Sin; 2007 Sep; 28(9):1373-82. PubMed ID: 17723171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.
    Nakagawa K; Kawaura A; Kato S; Takeda E; Okano T
    Carcinogenesis; 2005 Feb; 26(2):429-40. PubMed ID: 15539405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 25-hydroxyl group orientation on biological activity and binding to the 1alpha,25-dihydroxy vitamin D3 receptor.
    Collins ED; Bishop JE; Bula CM; Acevedo A; Okamura WH; Norman AW
    J Steroid Biochem Mol Biol; 2005 Mar; 94(4):279-88. PubMed ID: 15857747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side-chain modified vitamin D analogs induce rapid accumulation of VDR in the cell nuclei proportionately to their differentiation-inducing potential.
    Gocek E; Kiełbiński M; Wyłób P; Kutner A; Marcinkowska E
    Steroids; 2008 Dec; 73(14):1359-66. PubMed ID: 18644400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of growth arrest and CYP24 induction by VDR ligands in mammary tumor cells.
    Valrance ME; Brunet AH; Acosta A; Welsh J
    J Cell Biochem; 2007 Aug; 101(6):1505-19. PubMed ID: 17286279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D receptor-dependent inhibition of mammary tumor growth by EB1089 and ultraviolet radiation in vivo.
    Valrance ME; Brunet AH; Welsh J
    Endocrinology; 2007 Oct; 148(10):4887-94. PubMed ID: 17628009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for tissue- and cell-type selective activation of the vitamin D receptor by Ro-26-9228, a noncalcemic analog of vitamin D3.
    Peleg S; Ismail A; Uskokovic MR; Avnur Z
    J Cell Biochem; 2003 Feb; 88(2):267-73. PubMed ID: 12520525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S; Agoulnik IU; Weigel NL
    Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
    Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
    J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines.
    Evans SR; Houghton AM; Schumaker L; Brenner RV; Buras RR; Davoodi F; Nauta RJ; Shabahang M
    J Surg Res; 1996 Feb; 61(1):127-33. PubMed ID: 8769954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAPK inhibition by 1alpha,25(OH)2-Vitamin D3 in breast cancer cells. Evidence on the participation of the VDR and Src.
    Rossi AM; Capiati DA; Picotto G; Benassati S; Boland RL
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):287-90. PubMed ID: 15225787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable expression of human VDR in murine VDR-null cells recapitulates vitamin D mediated anti-cancer signaling.
    Keith ME; LaPorta E; Welsh J
    Mol Carcinog; 2014 Apr; 53(4):286-99. PubMed ID: 23681781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D receptor modulates the neoplastic phenotype through antagonistic growth regulatory signals.
    Xu H; McCann M; Zhang Z; Posner GH; Bingham V; El-Tanani M; Campbell FC
    Mol Carcinog; 2009 Aug; 48(8):758-72. PubMed ID: 19184984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
    Seifert M; Rech M; Meineke V; Tilgen W; Reichrath J
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):375-9. PubMed ID: 15225804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VDR-dependent regulation of mast cell maturation mediated by 1,25-dihydroxyvitamin D3.
    Baroni E; Biffi M; Benigni F; Monno A; Carlucci D; Carmeliet G; Bouillon R; D'Ambrosio D
    J Leukoc Biol; 2007 Jan; 81(1):250-62. PubMed ID: 17035339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vitamin D receptor in cancer.
    Thorne J; Campbell MJ
    Proc Nutr Soc; 2008 May; 67(2):115-27. PubMed ID: 18412986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.